Navigation Links
Malaria research wins Jake Baum a Young Tall Poppy award
Date:9/25/2009

Research aimed at developing drugs that stop malaria parasites from spreading throughout the body has seen Dr Jake Baum, from the Walter and Eliza Hall Institute, named a Young Tall Poppy by the Australian Institute of Policy and Science.

Dr Baum, a senior postdoctoral fellow in the institute's Infection and Immunity division, is investigating the molecular mechanisms that control the malaria parasite's movement.

"Malaria parasites use a unique actin-myosin motor that enables them to literally glide across cell surfaces and enter host cells," Dr Baum said. "The components of this gliding motor are well established yet we still know almost nothing about how motility is regulated."

Dr Baum hopes to identify the critical component that regulates the parasite's movement so that drugs can be developed that stop the parasite from spreading from the body's liver cells into the bloodstream.

"Through the development of drugs that prevent the malaria parasite's movement we hope to contain its spread and therefore prevent or treat malaria disease."

Malaria is one of the world's most prevalent diseases. It causes hundreds of millions of infections each year and is the greatest cause of infant death in large parts of Africa and South East Asia, killing a child every 30 seconds.

Dr Baum was one of 11 Young Tall Poppy winners from Victoria and Tasmania. He was presented with his award on 17 September by the Hon Robyn Parker, Member of the Legislative Council for New South Wales.

The Tall Poppy Campaign was created by the Australian Institute of Policy and Science to recognise and celebrate Australian scientific and intellectual excellence and to encourage younger Australians to follow in the footsteps of outstanding achievers.

Previous Tall Poppy award winners from the Walter and Eliza Hall Institute have been Dr Kylie Mason, Dr Ben Croker, Dr Benjamin Kile and Professors Brendan Crabb, Simon Foote and Doug Hilton.


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related biology news :

1. First genetically-engineered malaria vaccine to enter human trials
2. Vaccine blocks malaria transmission in lab experiments
3. New lead on malaria treatment
4. Bacteria play role in preventing spread of malaria
5. Alzheimers, asthma, cancer, malaria and TB focus of new Singapore grants
6. IVCC and Syngenta start project for novel insecticidal active ingredient for malaria control
7. New hope for advances in treating malaria
8. NIH funds development of resistance-breaking insecticides to reduce malaria transmission
9. Locking parasites in host cell could be new way to fight malaria
10. Malaria immunity trigger found for multiple mosquito species
11. Researchers identify new way the malaria parasite and red blood cells interact
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Malaria research wins Jake Baum a Young Tall Poppy award
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
(Date:1/23/2017)...  The latest mobile market research from Acuity Market ... The quarterly average price of a biometric smartphone decreased ... 2016.  There are now 120 sub-$150 models on the ... just 28 a year ago at an average price ... Most , Acuity Market Intelligence Principal, "Biometric Smartphones are ...
(Date:1/18/2017)... MedNet Solutions , an innovative ... spectrum of clinical research, is proud to announce ... the organization in terms of corporate growth, outside ... and services. The company,s exceptional achievements can be ... iMedNet ™ – MedNet,s ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... ... February 16, 2017 , ... EIT Digital ... aimed at the agricultural industry. Pilot studies are about to get under way for ... Big Data and 5G innovations. The concept is expected to be transferred eventually to ...
(Date:2/16/2017)... CALABASAS, Calif. , Feb. 16, 2017 /PRNewswire/ ... on developing groundbreaking therapies to treat severe neurological ... in children treated with AGT-181, the company,s investigational ... syndrome (also known as mucopolysaccharidosis type I, or ... Phase 2 proof-of-concept (POC) study, presented today at ...
(Date:2/16/2017)... -- UCHealth ( Aurora, Colorado ) becomes ... patient management. In addition to optimizing care coordination for ... lung, UCHealth looks to improve provider workflow by decreasing ... Stephanie Brown, RN , Thoracic Nurse Navigator, says, ... Excel spreadsheet, which was extremely arduous and susceptible to ...
(Date:2/16/2017)... BOSTON , Feb. 16, 2017 /PRNewswire/ ... for rare genetic deficiencies that result in ... of a $41 million mezzanine round of ... Ipsen, OrbiMed, MPM Capital, New Enterprise Associates, ... an undisclosed public healthcare investment fund. Rhythm ...
Breaking Biology Technology: